Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by MarketMoneyon Mar 08, 2021 7:27am
172 Views
Post# 32741288

RE:RE:RE:RE:RE:wow...congratulation to Tripp

RE:RE:RE:RE:RE:wow...congratulation to Tripp

I believe the COVID revenu is to stay as now we know this can happen again and again, new virus, new test, so we have a nice revenu from testing which the lab is made for! The company double in size and having a positive cashflow will prevent from needing future financing.

Since the CEO made that pivotal Leadership move to use their lab to test and create revenu, I firmly believe he has what it takes to make big decision for the company growth. I believe he saved the company the day he tooked that decision! 

As for ressources management, having many product/service offering will diversify employement and keep their employee busy during all year. 

If you look at the weekly chart, you clearly see it what a big change it made since February 2020, increase volume, increase shareprice and most importanly started a weekly stage 2 with a monthly stage 1 ready to support a very long progression for SZLS.

Have a great and safe day!

<< Previous
Bullboard Posts
Next >>